Desai MY, Owens A, Geske JB, Wolski K, et al. Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks. Circulation 2023;147:850-863.
PMID: 36335531